ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF

Department of Health and Human Services

Award: Department of Health and Human ServicesNAICS n/aSAM# HHSO100201700026C

Posted 2026-07-19 · Response deadline 2026-05-22 · Set-aside: None

Recipient: NOVARTIS PHARMACEUTICALS CORPORATION | $16334774.81

View official SAM.gov notice →

← All opportunities